October and November option contracts totals:
18,089 Call Contracts
7,192 Put Contracts
December contracts maintain essentially the same ratio if not more bullish.
Looks like this moves higher as it heads towards the PDUFA date in a few weeks.
Place your bet.
Implied Option Volatilty:
Option open interest 10/08/10
Oct calls 5,143 puts 1,978
Nov calls 12,940 puts 5,218
Dec calls 14,029 puts 6,693
March calls 14,149 puts 5,580
Total calls 46,261
2.37 to 1 “Very Bullish Indicator”
Current Market Cap Is About $100 Million. Sanofi-Aventis, Potential Suitor for Biodel, Has Spent Over $17 Billion for 25 Acquisitions the Last Two Years or an average of $645,000,000 per acquisition.
Sanofi-Aventis and Eli Lilly Are Potential Suitors:
Biodel Names Former Merrill Lynch Executive With Extensive International Experience to Board of Directors:
Upside With Linjeta’s Approval
Sanofi-Aventis, Potential Suitor for Biodel, Has Spent Over $17 Billion for 25 Acquisitions the Last Two Years:
with below average volume and a steady decline in price, I would say most are predicting the opposite. The call volume is exemplary of bets against the current negative sentiment - BUT, a lot less risk, heck, you never know with the FDA....roll those dice but not on my dime....on my penny.